Dochteronderneming PIP Hertitage

Artikel (link is helaas verdwenen)

Heritage Worldwide, Inc. Subsidiary PIP Receives European Regulatory Approval For World's First Titanium-Coated Breast Implants

NEW YORK, Sept. 9 /PRNewswire-FirstCall/

Introducing another world-first in breast implant technologies, Poly Implants

Protheses (PIP), a subsidiary of Heritage Worldwide, Inc. (OTC Bulletin Board:

HWWI), today announced that it has received CE Mark approval from the

European Union for its titanium-coated breast implants.

The Company has begun sales of the implants in France and is soon to expand sales into the rest of Europe. PIP's titanium-coated breast implants significantly reduce the body's rejection of foreign material and reduce leaks and microholes. These two conditions account for 69% of complications that lead to breast implant removal. Titanium, which is considered one of the most biocompatible materials, fully coats the implant and is the only part of the implant that comes in direct contact with the human body. Through an agreement with GFE Medizintechnik, a German company that is the world leader in titanium-coated medical devices, PIP has the exclusive license for titanium-coated breast implant technology for the next six years. "In our continuing quest to create the world's most advanced and safety-focused breast implants, we are very proud of having launched our titanium-coated implants in Europe. While we expect that this product will create a significant competitive advantage for us in the EU, we are also forging forward with preparing for approval processes in the U.S. and in other major markets," stated PIP President and CEO Mr. Jean Claude Mas.

About Heritage Worldwide: Heritage Worldwide, Inc. recently acquired France-based Poly Implants Protheses, S.A. (PIP), the third largest breast implant manufacturer in the world. PIP develops, manufactures, and markets a diverse line of such implants in a variety of shapes, sizes, and textures. PIP's products also include body support products and other implants and are sold in 40 countries across the globe. The Company plans to apply for FDA approval of its implants by early 2004. PIP has consistently been a leading innovator in the breast implant industry. It was the first company to introduce hydrogel breast prosthesis in 1992. A year later, PIP launched the first saline pre-filled breast implant with technology that provides unique advantages over inflatable implants. Last year PIP produced the first asymmetric prosthesis to alleviate the risk of rotation that is apparent in anatomical prostheses. Further information about the Company is available in a research report which can accessed at: Safe Harbor Statement: Certain statements made herein that are not historical are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the Company's beliefs and the assumptions it made using information currently available to it. Because these statements reflect the Company's current views concerning future events, these statements involve risks, uncertainties and assumptions. The actual results could differ materially from the results discussed in the forward-looking statements. In any event, undue reliance should not be placed on any forward-looking statements, which apply only as of the date of this press release.

SOURCE Heritage Worldwide, Inc.